高乳酸血症
可穿戴计算机
生物医学工程
病危
医学
微透析
重症监护医学
危重病
持续监测
血乳酸
计算机科学
光容积图
分析物
材料科学
重症监护
生物传感器
注意事项
模拟
作者
Yunxiang Long,Xiaosen Pan,Yao Chen,N Li,Wentong Wang,Yue Wang,Wanyu Zhang,Taozhe Liu,Qiuting Peng,Kun Yang,Guorui Jin,Chang Liu,Jian Lv,Feng Xu,Kai Qu,Yunsheng Fang,Yu Song,Ting Lin
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-10-12
卷期号:20 (42): 28602-28616
标识
DOI:10.1021/acsnano.6c12805
摘要
Hyperlactatemia is a critical indicator of tissue hypoperfusion, metabolic dysfunction, and an adverse prognosis in critically ill patients. Yet conventional monitoring depends entirely on intermittent, invasive blood sampling, which cannot capture the dynamic metabolic fluctuations required to guide timely clinical interventions. Herein, we report a wearable sweat-sensing device built on a dual-diffusion-limiting architecture for the continuous and accurate assessment of clinical hyperlactatemia. This system synergistically modulates lactate diffusion in sweat through a silane-network-encapsulated lactate oxidase layer coupled to a polyvinyl chloride layer. This design effectively delays enzyme saturation, extending the linear detection range for sweat lactate to 0-60 mM and thereby fulfilling the stringent requirements of critical care monitoring. The device also integrates real-time pH and temperature calibration to safeguard measurement accuracy in complex physiological environments. Moreover, linear mixed-effects analysis of 82 paired samples from 33 critically ill patients demonstrated a strong association between sweat and blood lactate levels, with a marginal R2 of 0.840. Sweat lactate effectively identified hyperlactatemia and predicted in-hospital mortality, yielding areas under the receiver operating characteristic curve values of 0.943 and 0.785, respectively. The integrated iontophoresis-microfluidics module further ensures high consistency with bedside arterial blood gas analysis, as validated by a marginal R2 of 0.811. Together, these results establish sweat biosensors as a promising platform for continuous metabolic monitoring, resuscitation assessment, and objective prognostic stratification in critical care settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI